Teladoc stock drops after another quarterly loss for telemedicine company

5
2
Favorite

Teladoc stock drops after another quarterly loss for telemedicine company

Dow Jones2022-02-23

MW Teladoc stock drops after another quarterly loss for telemedicine company

Shares of Teladoc Health Inc. (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw "meaningful growth and penetration across several key areas of our business," including mental health and primary care. "Healthcare has a 'new normal,'" Teladoc said. "We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate." Shares of Teladoc ended the regular trading day up 0.5%.

-Claudia Assis

$(END)$ Dow Jones Newswires

February 22, 2022 17:23 ET (22:23 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（2）

Alexiss
·2022-02-23
👍🏻
Reply
1
Report
Chong135
·2022-02-23
The outlook shows that even the senior management thinks they not gonna grow by a large margin because : 1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help 2. People's behaviour has not really switched to tele health services much Therefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2213495760?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-02-23 06:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2213495760","market":"us","top_or_hot":-1,"title":"Teladoc stock drops after another quarterly loss for telemedicine company","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Teladoc stock drops after another quarterly loss for telemedicine company\n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/TDOC\">Teladoc Health Inc.</a> (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n</p>\n<p>\n  -Claudia Assis \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 22, 2022 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc stock drops after another quarterly loss for telemedicine company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc stock drops after another quarterly loss for telemedicine company\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-23 06:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc Health Inc. (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a ...</p>\n\n<a href=\"http://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2213495760","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2213495760","pubTimestamp":1645568580,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc H","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4504":"桥水持仓","BK4548":"巴美列捷福持仓","BK4167":"医疗保健技术","TDOC":"Teladoc Health Inc."},"translate_title":"远程医疗公司Teladoc股价再次出现季度亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc Health Inc. (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n\n\n  -Claudia Assis \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  February 22, 2022 17:23 ET (22:23 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9030058592,"gmtCreate":1645584235827,"gmtModify":1676534042919,"author":{"id":"4093827796988890","authorId":"4093827796988890","name":"Alexiss","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":1,"idStr":"4093827796988890","authorIdStr":"4093827796988890"},"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030058592","repostId":2213495760,"repostType":2,"repost":{"id":"2213495760","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1645568580,"share":"https://ttm.financial/m/news/2213495760?lang=&edition=fundamental","pubTime":"2022-02-23 06:23","market":"us","language":"en","title":"Teladoc stock drops after another quarterly loss for telemedicine company","url":"https://stock-news.laohu8.com/highlight/detail?id=2213495760","media":"Dow Jones","summary":"MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc H","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Teladoc stock drops after another quarterly loss for telemedicine company\n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/TDOC\">Teladoc Health Inc.</a> (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n</p>\n<p>\n  -Claudia Assis \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 22, 2022 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc stock drops after another quarterly loss for telemedicine company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc stock drops after another quarterly loss for telemedicine company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-02-23 06:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Teladoc stock drops after another quarterly loss for telemedicine company\n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/TDOC\">Teladoc Health Inc.</a> (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n</p>\n<p>\n  -Claudia Assis \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 22, 2022 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4504":"桥水持仓","BK4567":"ESG概念","BK4167":"医疗保健技术","BK4534":"瑞士信贷持仓","TDOC":"Teladoc Health Inc.","BK4548":"巴美列捷福持仓"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2213495760","content_text":"MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc Health Inc. (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n\n\n  -Claudia Assis \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  February 22, 2022 17:23 ET (22:23 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9030065075,"gmtCreate":1645581504441,"gmtModify":1676534042562,"author":{"id":"3578357426454921","authorId":"3578357426454921","name":"Chong135","avatar":"https://static.tigerbbs.com/1c56125729fc95aa1f1d4e0cfc2edea1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3578357426454921","authorIdStr":"3578357426454921"},"htmlText":"The outlook shows that even the senior management thinks they not gonna grow by a large margin because : 1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help 2. People's behaviour has not really switched to tele health services much Therefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.","listText":"The outlook shows that even the senior management thinks they not gonna grow by a large margin because : 1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help 2. People's behaviour has not really switched to tele health services much Therefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.","text":"The outlook shows that even the senior management thinks they not gonna grow by a large margin because : 1. Omnicron not as deadly so people's mentality not as afraid and hence don't really need to visit doctor for help 2. People's behaviour has not really switched to tele health services much Therefore, we might need to see some sort of behavioural change in people for them to spark the growth they hope for.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030065075","repostId":2213495760,"repostType":2,"repost":{"id":"2213495760","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1645568580,"share":"https://ttm.financial/m/news/2213495760?lang=&edition=fundamental","pubTime":"2022-02-23 06:23","market":"us","language":"en","title":"Teladoc stock drops after another quarterly loss for telemedicine company","url":"https://stock-news.laohu8.com/highlight/detail?id=2213495760","media":"Dow Jones","summary":"MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc H","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Teladoc stock drops after another quarterly loss for telemedicine company\n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/TDOC\">Teladoc Health Inc.</a> (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n</p>\n<p>\n  -Claudia Assis \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 22, 2022 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teladoc stock drops after another quarterly loss for telemedicine company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeladoc stock drops after another quarterly loss for telemedicine company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-02-23 06:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Teladoc stock drops after another quarterly loss for telemedicine company\n</p>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/TDOC\">Teladoc Health Inc.</a> (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n</p>\n<p>\n  -Claudia Assis \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 22, 2022 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4504":"桥水持仓","BK4567":"ESG概念","BK4167":"医疗保健技术","BK4534":"瑞士信贷持仓","TDOC":"Teladoc Health Inc.","BK4548":"巴美列捷福持仓"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2213495760","content_text":"MW Teladoc stock drops after another quarterly loss for telemedicine company\n\n\n  Shares of Teladoc Health Inc. (TDOC) fell more than 6% in the extended session Tuesday after investors looked past a narrower quarterly loss and sales that were above expectations. Teladoc said it lost $11 million, or 7 cents a share, in the fourth quarter, compared with a loss of $394 million, or $3.07 a share, in the year-ago period. Revenue rose 45% to $554.2 million, Teladoc said. Analysts polled by FactSet expected the company to report a loss of 57 cents a share on sales of  $547 million. Teladoc guided for full-year 2022 sales of between $2.55 billion and $2.65 billion, representing 25% to 30% growth and, at the top of the range, in line with expectations. The telemedicine company said it saw \"meaningful growth and penetration across several key areas of our business,\" including mental health and primary care. \"Healthcare has a 'new normal,'\" Teladoc said. \"We are proud of the role Teladoc Health has played in leading this transformation and are equally excited about our role in 2022 and beyond as we continue to innovate.\" Shares of Teladoc ended the regular trading day up 0.5%. \n\n\n  -Claudia Assis \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  February 22, 2022 17:23 ET (22:23 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":5,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}